Neo-Tran
Category
Neo-Tran Brand names, Neo-Tran Analogs
Neo-Tran Brand Names Mixture
Neo-Tran Chemical_Formula
C20H23NS
Neo-Tran RX_link
No information avaliable
Neo-Tran fda sheet
Neo-Tran msds (material safety sheet)
Neo-Tran Synthesis Reference
No information avaliable
Neo-Tran Molecular Weight
309.469 g/mol
Neo-Tran Melting Point
< 25 oC
Neo-Tran H2O Solubility
Soluble as HCl salt
Neo-Tran State
Liquid
Neo-Tran LogP
5.7
Neo-Tran Dosage Forms
Tablets (oral, 1 mg)
Neo-Tran Indication
Used for the symptomatic treatment of parkinsonism.
Neo-Tran Pharmacology
Metixene is a tertiary antimuscarinic with actions similar to those of atropine; it also has antihistaminic and direct antispasmodic properties. It is used for the symptomatic treatment of parkinsonism, including the alleviation of the extrapyramidal syndrome induced by other drugs such as phenothiazines, but, like other antimuscarinics, it is of no value against tardive dyskinesias. Metixene has been discontinued.
Neo-Tran Absorption
Absorbed in the gastrointestinal tract following oral administration, however the extent of absorption is not known.
Neo-Tran side effects and Toxicity
Signs of overdose include dilated and sluggish pupils, warm, dry skin, facial flushing, decreased secretions of the mouth, pharynx, nose, and bronchi, foul-smelling breath, elevated temperature, tachycardia, cardiac arrhythmias, decreased bowel sounds, urinary retention, delirium, disorientation, anxiety, hallucinations, illusions, confusion, incoherence, agitation, hyperactivity, ataxia, loss of memory, paranoia, combativeness, and seizures.
Neo-Tran Patient Information
Neo-Tran Organisms Affected
Humans and other mammals
